Entera Bio regains Nasdaq minimum bid price compliance, delisting risk removed

Entera Bio Ltd.

Received Nasdaq notice on March 1, 2024 confirming bid price compliance.
Ordinary shares closed at $1.00+ for 10 consecutive business days to satisfy rule.
Listing matter is now closed; no further action required.
Press release issued March 4, 2024 announcing the compliance.

item 7.01 item 9.01

Entera Bio Ltd. filing history →

Source: SEC EDGAR

accession 0001178913-24-000794

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.